Iosief Abraha

Summary

Country: Italy

Publications

  1. pmc Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study
    Iosief Abraha
    Health Planning Service, Regional Health Authority of Umbria, Department of Epidemiology, 06124 Perugia, Italy
    BMJ 350:h2445. 2015
  2. ncbi Statin compliance in the Umbrian population
    Iosief Abraha
    Assessorato alla Sanità, Regione Umbria, Epidemiology Department, via Mario Angeloni, 06124 Perugia, Italy
    Eur J Clin Pharmacol 59:659-61. 2003
  3. pmc Modified intention to treat reporting in randomised controlled trials: systematic review
    Iosief Abraha
    Regional Health Authority of Umbria, Via Mario Angeloni 61, 06123 Perugia, Italy
    BMJ 340:c2697. 2010
  4. pmc Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
    Alessandro Montedori
    Regional Health Authority of Umbria, Perugia, Italy
    Trials 12:58. 2011
  5. doi Thoracic stent graft versus surgery for thoracic aneurysm
    Iosief Abraha
    Epidemiology Department, Regional Health Authority of Umbria, via Mario Angeloni, 61, Perugia, Italy, 06124
    Cochrane Database Syst Rev 9:CD006796. 2013
  6. pmc Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs
    Giuseppe Traversa
    Department of Epidemiology, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
    BMJ 327:18-22. 2003
  7. ncbi Efficacy and safety of cholesterol-lowering treatment
    Iosief Abraha
    Lancet 367:469; author reply 470-1. 2006

Collaborators

Detail Information

Publications7

  1. pmc Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study
    Iosief Abraha
    Health Planning Service, Regional Health Authority of Umbria, Department of Epidemiology, 06124 Perugia, Italy
    BMJ 350:h2445. 2015
    ..To examine whether deviation from the standard intention to treat analysis has an influence on treatment effect estimates of randomised trials...
  2. ncbi Statin compliance in the Umbrian population
    Iosief Abraha
    Assessorato alla Sanità, Regione Umbria, Epidemiology Department, via Mario Angeloni, 06124 Perugia, Italy
    Eur J Clin Pharmacol 59:659-61. 2003
    ..To explore compliance with statin treatment over a period of 4.5 years follow-up in an Italian population and to investigate the degree of persistence and continuity in subjects with cardiovascular diseases...
  3. pmc Modified intention to treat reporting in randomised controlled trials: systematic review
    Iosief Abraha
    Regional Health Authority of Umbria, Via Mario Angeloni 61, 06123 Perugia, Italy
    BMJ 340:c2697. 2010
    ..To determine the incidence and characteristics of randomised controlled trials that report using the modified intention to treat approach, and how the approach is described...
  4. pmc Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study
    Alessandro Montedori
    Regional Health Authority of Umbria, Perugia, Italy
    Trials 12:58. 2011
    ....
  5. doi Thoracic stent graft versus surgery for thoracic aneurysm
    Iosief Abraha
    Epidemiology Department, Regional Health Authority of Umbria, via Mario Angeloni, 61, Perugia, Italy, 06124
    Cochrane Database Syst Rev 9:CD006796. 2013
    ..Evidence is needed to support the use of TEVAR for these patients, rather than open surgery...
  6. pmc Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs
    Giuseppe Traversa
    Department of Epidemiology, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy
    BMJ 327:18-22. 2003
    ..To estimate the risk of acute hepatotoxicity associated with nimesulide compared with other non-steroidal anti-inflammatory drugs...
  7. ncbi Efficacy and safety of cholesterol-lowering treatment
    Iosief Abraha
    Lancet 367:469; author reply 470-1. 2006